Not surprised. We finally get a trail update and it's a fizzer.
2 and a half years and only half way through a 25 patient trial. At this rate we could expect final results sometime in 2026.
Results so far underwhelming and investigator having to lower the starting dose due to tolerability issues.
Ann: Preliminary update from ongoing Phase 2 Study of Paxalisib, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)